Role of the PKCα-c-Src tyrosine kinase pathway in the mediation of p120-catenin degradation in ventilator-induced lung injury

Respirology ◽  
2016 ◽  
Vol 21 (8) ◽  
pp. 1404-1410 ◽  
Author(s):  
Tao Zhao ◽  
Hongwei Zhao ◽  
Gang Li ◽  
Shengfa Zheng ◽  
Mengjie Liu ◽  
...  
2019 ◽  
Vol 23 (11) ◽  
pp. 7360-7371 ◽  
Author(s):  
Ge Liu ◽  
Changping Gu ◽  
Mengjie Liu ◽  
Huan Liu ◽  
Dong Wang ◽  
...  

2018 ◽  
Vol 131 (7) ◽  
pp. 804-812
Author(s):  
Jian-Lei Qiu ◽  
Bai-Ling Song ◽  
Yu-Juan Wang ◽  
Fu-Tao Zhang ◽  
Yue-Lan Wang

2018 ◽  
Vol 19 (1) ◽  
pp. 114 ◽  
Author(s):  
Vidyani Suryadevara ◽  
Panfeng Fu ◽  
David Ebenezer ◽  
Evgeny Berdyshev ◽  
Irina Bronova ◽  
...  

Cancers ◽  
2020 ◽  
Vol 12 (10) ◽  
pp. 2860 ◽  
Author(s):  
Filippo Torrisi ◽  
Nunzio Vicario ◽  
Federica M. Spitale ◽  
Francesco P. Cammarata ◽  
Luigi Minafra ◽  
...  

Advances in functional imaging are supporting neurosurgery and radiotherapy for glioblastoma, which still remains the most aggressive brain tumor with poor prognosis. The typical infiltration pattern of glioblastoma, which impedes a complete surgical resection, is coupled with a high rate of invasiveness and radioresistance, thus further limiting efficient therapy, leading to inevitable and fatal recurrences. Hypoxia is of crucial importance in gliomagenesis and, besides reducing radiotherapy efficacy, also induces cellular and molecular mediators that foster proliferation and invasion. In this review, we aimed at analyzing the biological mechanism of glioblastoma invasiveness and radioresistance in hypoxic niches of glioblastoma. We also discussed the link between hypoxia and radiation-induced radioresistance with activation of SRC proto-oncogene non-receptor tyrosine kinase, prospecting potential strategies to overcome the current limitation in glioblastoma treatment.


Author(s):  
Gerard F. Curley ◽  
Mairead Hayes ◽  
Maya Contreras ◽  
Brendan D. Higgins ◽  
Daniel P. O'Toole ◽  
...  

Blood ◽  
2005 ◽  
Vol 106 (12) ◽  
pp. 3907-3916 ◽  
Author(s):  
Chiara Ambrogio ◽  
Claudia Voena ◽  
Andrea D. Manazza ◽  
Roberto Piva ◽  
Ludovica Riera ◽  
...  

Translocations of the anaplastic lymphoma kinase (ALK) gene have been described in anaplastic large-cell lymphomas (ALCLs) and in stromal tumors. The most frequent translocation, t(2;5), generates the fusion protein nucleophosmin (NPM)–ALK with intrinsic tyrosine kinase activity. Along with transformation, NPM-ALK induces morphologic changes in fibroblasts and lymphoid cells, suggesting a direct role of ALK in cell shaping. In this study, we used a mass-spectrometry–based proteomic approach to search for proteins involved in cytoskeleton remodeling and identified p130Cas (p130 Crk-associated substrate) as a novel interactor of NPM-ALK. In 293 cells and in fibroblasts as well as in human ALK-positive lymphoma cell lines, NPM-ALK was able to bind p130Cas and to induce its phosphorylation. Both of the effects were dependent on ALK kinase activity and on the adaptor protein growth factor receptor–bound protein 2 (Grb2), since no binding or phosphorylation was found with the kinase-dead mutant NPM-ALKK210R or in the presence of a Grb2 dominant-negative protein. Phosphorylation of p130Cas by NPM-ALK was partially independent from Src (tyrosine kinase pp60c-src) kinase activity, as it was still detectable in Syf-/- cells. Finally, p130Cas-/- (also known as Bcar1-/-) fibroblasts expressing NPM-ALK showed impaired actin filament depolymerization and were no longer transformed compared with wild-type cells, indicating an essential role of p130Cas activation in ALK-mediated transformation.


Sign in / Sign up

Export Citation Format

Share Document